Lazuna, Merlina .

HRN: 24-05-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2025
CEFUROXIME 500MG (TAB)
08/09/2025
08/16/2025
PO
500 Mg
Q12 Hrs
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: